Mebicar IC (mebicar) tablets 0.3 g. №20

Description

Mebicar IC composition
active substance: mebicar;
1 tablet contains mebicar 300 mg (0.3 g);
excipients: methylcellulose, calcium stearate.

Dosage form
Tablets.

Pharmacological properties
This drug Mebicar IC belongs to the group of sedative drugs – psychostimulants. It is also effective in the developed syndrome characterized by the appearance of attention deficit disorder, including if the patient has hyperactivity.
The main active ingredient of the drug is mebikar. It is a nootropic drug closely related in its structure to natural metabolites. In particular, the molecule of this substance contains two fragments of urea. The latter are part of bicyclic structures.
Mebicar IC produces a mild sedative (tranquilizing) effect. Able to reduce feelings of fear, anxiety, anxiety. Taking the drug leads to a decrease in internal emotional stress, irritability.
The drug is favorably distinguished by the absence of a muscle relaxant effect. Thus, the human body retains muscle tone, motor or mental activity does not decrease.
Does not cause feelings of euphoria. Not being a hypnotic in itself, nevertheless, it improves the quality of sleep – the process of falling asleep is accelerated, and the effectiveness of hypnotics increases.
It is a nootropic drug – it increases mental abilities, increases attention and performance.
It is also an antioxidant and membrane stabilizer. Helps to alleviate nicotine withdrawal symptoms.

Indications
This drug Mebicar IC can be recommended and used as a drug used in the treatment and prevention of neuroses and neurosis-like conditions, accompanied by irritation, emotional lability, anxiety and fear to improve the tolerance of neuroleptics or tranquilizers in order to eliminate the somatovegetative and neurological side effects of cardialgia caused by them. of various origins (not associated with coronary heart disease).
It is also used as part of the complex therapy of nicotine addiction as a means of reducing the craving for smoking.

Contraindications
The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or to one of the auxiliary components.
Use with caution when:

• arterial hypotension;
• disorders of the kidneys or liver.

Combined use with antipsychotics, tranquilizers (benzodiazepines), hypnotics, antidepressants and psychostimulants is allowed.

Children
The drug is not intended for use in children.

Application during pregnancy and lactation
This drug is not used in the treatment of pregnant women and women during lactation.

Method of administration and dosage
The dosage, regimens and duration of treatment are determined by the attending physician on an individual basis, depending on the nature and course of the disease.
The average dosage is 200-300 mg, 2-3 times a day.
If necessary, the dosage can be increased, but not more than 10 grams per day.
The duration of the treatment course is up to 2-3 months.
With withdrawal symptoms during withdrawal from nicotine withdrawal, take 600-900 mg three times a day for 5-6 weeks.
Do not exceed the recommended dosage during therapy.
The patient should consult a doctor if the symptoms of the disease did not disappear during the use of the drug or if adverse reactions are observed that are not indicated in the instructions for medical use of the drug.

Overdose
The drug is low toxic.
If the overdose was significant, then the drug can cause:

• allergic reactions;
• digestive disorders;
• lowering blood pressure;
• decrease in body temperature.

Side effects
Adverse reactions may occur. In this case, such reactions are possible as:

• decrease in blood pressure, body temperature;
• dyspeptic disorders (nausea, vomiting, diarrhea);
• bronchospasm;
• allergic reactions, rash, itching, allergic urticaria.

Storage conditions and periods
Shelf life – 4 years from the date of manufacture indicated on the package.
The storage temperature of Mebicar IC should not exceed 25 ° C.